164 related articles for article (PubMed ID: 11418131)
1. Molecular structure of the glibenclamide binding site of the beta-cell K(ATP) channel.
Mikhailov MV; Mikhailova EA; Ashcroft SJ
FEBS Lett; 2001 Jun; 499(1-2):154-60. PubMed ID: 11418131
[TBL] [Abstract][Full Text] [Related]
2. Investigation of the molecular assembly of beta-cell K(ATP) channels.
Mikhailov MV; Mikhailova EA; Ashcroft SJ
FEBS Lett; 2000 Sep; 482(1-2):59-64. PubMed ID: 11018523
[TBL] [Abstract][Full Text] [Related]
3. Structure-function relationships in the beta-cell K(ATP) channel.
Mikhailov MV; Mikhailova EA; Ashcroft SJ
Biochem Soc Trans; 2002 Apr; 30(2):323-7. PubMed ID: 12023873
[TBL] [Abstract][Full Text] [Related]
4. Interactions of the sulfonylurea receptor 1 subunit in the molecular assembly of beta-cell K(ATP) channels.
Mikhailov MV; Ashcroft SJ
J Biol Chem; 2000 Feb; 275(5):3360-4. PubMed ID: 10652326
[TBL] [Abstract][Full Text] [Related]
5. Characterization of low-affinity binding sites for glibenclamide on the Kir6.2 subunit of the beta-cell KATP channel.
Gros L; Virsolvy A; Salazar G; Bataille D; Blache P
Biochem Biophys Res Commun; 1999 Apr; 257(3):766-70. PubMed ID: 10208857
[TBL] [Abstract][Full Text] [Related]
6. Cooperative binding of ATP and MgADP in the sulfonylurea receptor is modulated by glibenclamide.
Ueda K; Komine J; Matsuo M; Seino S; Amachi T
Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1268-72. PubMed ID: 9990013
[TBL] [Abstract][Full Text] [Related]
7. Kir6.2-dependent high-affinity repaglinide binding to beta-cell K(ATP) channels.
Hansen AM; Hansen JB; Carr RD; Ashcroft FM; Wahl P
Br J Pharmacol; 2005 Feb; 144(4):551-7. PubMed ID: 15678092
[TBL] [Abstract][Full Text] [Related]
8. H3 domain of syntaxin 1A inhibits KATP channels by its actions on the sulfonylurea receptor 1 nucleotide-binding folds-1 and -2.
Cui N; Kang Y; He Y; Leung YM; Xie H; Pasyk EA; Gao X; Sheu L; Hansen JB; Wahl P; Tsushima RG; Gaisano HY
J Biol Chem; 2004 Dec; 279(51):53259-65. PubMed ID: 15485808
[TBL] [Abstract][Full Text] [Related]
9. Tissue specificity of sulfonylureas: studies on cloned cardiac and beta-cell K(ATP) channels.
Gribble FM; Tucker SJ; Seino S; Ashcroft FM
Diabetes; 1998 Sep; 47(9):1412-8. PubMed ID: 9726229
[TBL] [Abstract][Full Text] [Related]
10. Identification of the high-affinity tolbutamide site on the SUR1 subunit of the K(ATP) channel.
Ashfield R; Gribble FM; Ashcroft SJ; Ashcroft FM
Diabetes; 1999 Jun; 48(6):1341-7. PubMed ID: 10342826
[TBL] [Abstract][Full Text] [Related]
11. Unresponsiveness to glibenclamide during chronic treatment induced by reduction of ATP-sensitive K+ channel activity.
Kawaki J; Nagashima K; Tanaka J; Miki T; Miyazaki M; Gonoi T; Mitsuhashi N; Nakajima N; Iwanaga T; Yano H; Seino S
Diabetes; 1999 Oct; 48(10):2001-6. PubMed ID: 10512365
[TBL] [Abstract][Full Text] [Related]
12. Proximal C-terminal domain of sulphonylurea receptor 2A interacts with pore-forming Kir6 subunits in KATP channels.
Rainbow RD; James M; Hudman D; Al Johi M; Singh H; Watson PJ; Ashmole I; Davies NW; Lodwick D; Norman RI
Biochem J; 2004 Apr; 379(Pt 1):173-81. PubMed ID: 14672537
[TBL] [Abstract][Full Text] [Related]
13. Four novel splice variants of sulfonylurea receptor 1.
Hambrock A; Preisig-Müller R; Russ U; Piehl A; Hanley PJ; Ray J; Daut J; Quast U; Derst C
Am J Physiol Cell Physiol; 2002 Aug; 283(2):C587-98. PubMed ID: 12107069
[TBL] [Abstract][Full Text] [Related]
14. Regulated expression of adenosine triphosphate-sensitive potassium channel subunits in pancreatic beta-cells.
Moritz W; Leech CA; Ferrer J; Habener JF
Endocrinology; 2001 Jan; 142(1):129-38. PubMed ID: 11145575
[TBL] [Abstract][Full Text] [Related]
15. Syntaxin-1A inhibits cardiac KATP channels by its actions on nucleotide binding folds 1 and 2 of sulfonylurea receptor 2A.
Kang Y; Leung YM; Manning-Fox JE; Xia F; Xie H; Sheu L; Tsushima RG; Light PE; Gaisano HY
J Biol Chem; 2004 Nov; 279(45):47125-31. PubMed ID: 15339904
[TBL] [Abstract][Full Text] [Related]
16. Interaction of the sulfonylthiourea HMR 1833 with sulfonylurea receptors and recombinant ATP-sensitive K(+) channels: comparison with glibenclamide.
Russ U; Lange U; Löffler-Walz C; Hambrock A; Quast U
J Pharmacol Exp Ther; 2001 Dec; 299(3):1049-55. PubMed ID: 11714894
[TBL] [Abstract][Full Text] [Related]
17. Characterization of two novel forms of the rat sulphonylurea receptor SUR1A2 and SUR1BDelta31.
Gros L; Trapp S; Dabrowski M; Ashcroft FM; Bataille D; Blache P
Br J Pharmacol; 2002 Sep; 137(1):98-106. PubMed ID: 12183335
[TBL] [Abstract][Full Text] [Related]
18. Selectivity of repaglinide and glibenclamide for the pancreatic over the cardiovascular K(ATP) channels.
Stephan D; Winkler M; Kühner P; Russ U; Quast U
Diabetologia; 2006 Sep; 49(9):2039-48. PubMed ID: 16865362
[TBL] [Abstract][Full Text] [Related]
19. Glibenclamide binding to sulphonylurea receptor subtypes: dependence on adenine nucleotides.
Hambrock A; Löffler-Walz C; Quast U
Br J Pharmacol; 2002 Aug; 136(7):995-1004. PubMed ID: 12145099
[TBL] [Abstract][Full Text] [Related]
20. PKA-mediated phosphorylation of the human K(ATP) channel: separate roles of Kir6.2 and SUR1 subunit phosphorylation.
Béguin P; Nagashima K; Nishimura M; Gonoi T; Seino S
EMBO J; 1999 Sep; 18(17):4722-32. PubMed ID: 10469651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
